Garmey, Edward
2 papers on CoChat
Most cited papers
- Verified
Early clinical development of ARQ 197, a selective, non-ATP-competitive inhibitor targeting MET tyrosine kinase for the treatment of advanced cancers.
Adjei, A. A., Schwartz, B., & Garmey, E. (2011) · The Oncologist
Lung Cancer Treatments and MutationsCancer Mechanisms and Therapy
Cited by 73
- Verified
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas
Pearson, A. D., Gaspar, N., Janeway, K., Campbell-Hewson, Q., Lawlor, E. R., Copland, C., Karres, D., Norga, K., Benzaghou, F., Weiner, S., et al. (2022) · European Journal of Cancer
Sarcoma Diagnosis and TreatmentPharmaceutical studies and practices
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free